Cargando…

A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity

Infection with equid herpesvirus type 1 (EHV-1) leads to respiratory disease, abortion, and neurologic disorders in horses. Molecular epidemiology studies have demonstrated that a single nucleotide polymorphism resulting in an amino acid variation of the EHV-1 DNA polymerase (N752/D752) is significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goodman, Laura B, Loregian, Arianna, Perkins, Gillian A, Nugent, Josie, Buckles, Elizabeth L, Mercorelli, Beatrice, Kydd, Julia H, Palù, Giorgio, Smith, Ken C, Osterrieder, Nikolaus, Davis-Poynter, Nicholas
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2065875/ https://www.ncbi.nlm.nih.gov/pubmed/17997600 http://dx.doi.org/10.1371/journal.ppat.0030160

Ejemplares similares

A Point Mutation in a Herpesvirus Co-Determines Neuropathogenicity and Viral Shedding
por: Franz, Mathias, et al.
Publicado: (2017)

Drug Repurposing for Viral Infectious Diseases: How Far Are We?
por: Mercorelli, Beatrice, et al.
Publicado: (2018)

Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism
por: Loregian, Arianna, et al.
Publicado: (2007)

Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
por: Mercorelli, Beatrice, et al.
Publicado: (2011)

Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on “The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts”
por: Mercorelli, Beatrice, et al.
Publicado: (2019)

Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
por: Schnabel, Christiane L., et al.
Publicado: (2018)

A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells
por: Messa, Lorenzo, et al.
Publicado: (2018)

Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication
por: Ghassabian, Hanieh, et al.
Publicado: (2021)

The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib
por: Messa, Lorenzo, et al.
Publicado: (2021)

The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Is Modified by SUMO in a DNA-Dependent Manner
por: Sinigalia, Elisa, et al.
Publicado: (2012)

The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses
por: Wimer, Christine L., et al.
Publicado: (2018)

Detection of the neuropathogenic variant of equine herpesvirus 1 associated with abortions in mares in Poland
por: Stasiak, Karol, et al.
Publicado: (2015)

Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells
por: Celegato, Marta, et al.
Publicado: (2021)

The herpesvirus stealth program
por: Huang, Teng, et al.
Publicado: (2015)

Molecular characterization of Brazilian equid herpesvirus type 1 strains based on neuropathogenicity markers
por: Mori, Enio, et al.
Publicado: (2015)

Screening Pesticides for Neuropathogenicity
por: Doherty, John D.
Publicado: (2006)

Outbreak of neuropathogenic equid herpesvirus 1 causing abortions in Yili horses of Zhaosu, North Xinjiang, China
por: Tong, Panpan, et al.
Publicado: (2022)

The effect of siRNA treatment on experimental equine herpesvirus type 1 (EHV-1) infection in horses
por: Brosnahan, Margaret M., et al.
Publicado: (2010)

NEUROPATHOGENICITY OF GROUP A COXSACKIE VIRUSES
por: Dalldorf, Gilbert
Publicado: (1957)

Herpesvirus Telomerase RNA (vTR) with a Mutated Template Sequence Abrogates Herpesvirus-Induced Lymphomagenesis
por: Kaufer, Benedikt B., et al.
Publicado: (2011)

Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes
por: Yeo, Wee Ming, et al.
Publicado: (2013)

Measles Fusion Machinery Is Dysregulated in Neuropathogenic Variants
por: Jurgens, Eric M., et al.
Publicado: (2015)

Microglia and astrocyte responses to neuropathogenic protozoan parasites
por: Nasuhidehnavi, Azadeh, et al.
Publicado: (2021)

Indomethacin-based PROTACs as pan-coronavirus antiviral agents
por: Desantis, Jenny, et al.
Publicado: (2021)

Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo
por: Parthasarathy, Geetha, et al.
Publicado: (2022)

Übertragungswege neuropathogener Erreger – mögliche Mechanismen der Neuroinvasion
por: Craemer, Eva Maria
Publicado: (2023)

Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization
por: Eschke, Kathrin, et al.
Publicado: (2018)

The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding
por: Azab, Walid, et al.
Publicado: (2012)

Equid Herpesvirus Type 1 Activates Platelets
por: Stokol, Tracy, et al.
Publicado: (2015)

Long term stability and infectivity of herpesviruses in water
por: Dayaram, Anisha, et al.
Publicado: (2017)

Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation
por: Kaufer, Benedikt B., et al.
Publicado: (2011)

Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference
por: Fulton, Amy, et al.
Publicado: (2009)

Regulated Transport into the Nucleus of Herpesviridae DNA Replication Core Proteins
por: Gualtiero, Alvisi, et al.
Publicado: (2013)

Correction: Equid Herpesvirus Type 1 Activates Platelets
por: Stokol, Tracy, et al.
Publicado: (2020)

Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis
por: Walter, Jasmin, et al.
Publicado: (2013)

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization
por: Mercorelli, Beatrice, et al.
Publicado: (2022)

CCT complex restricts neuropathogenic protein aggregation via autophagy
por: Pavel, Mariana, et al.
Publicado: (2016)

Bioconversion of Tyrosine- and Tryptophan-Derived Biogenic Amines by Neuropathogenic Bacteria
por: Taj, Aneela, et al.
Publicado: (2018)

Study of Usutu virus neuropathogenicity in mice and human cellular models
por: Clé, Marion, et al.
Publicado: (2020)

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
por: Bauer, Lisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lt7pfluntf8b4fvgdbhq80eher